Jodid (Potassium Iodide)

Potassium iodide releases iodide ions that are rapidly taken up by the thyroid via the sodium‑iodide symporter. The excess stable iodide temporarily blocks the organification of iodine, limiting the gland’s ability to absorb additional (including radioactive) iodine and thereby shielding thyroid tissue.

The appropriate dose of Jodid is determined by a qualified prescriber based on the specific clinical situation, such as the level of radiation exposure risk or the degree of iodine deficiency. Patients should follow the dosing instructions provided by their healthcare professional.

Safety of potassium iodide in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Jodid.

To order Jodid, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Jodid provides potassium iodide in an oral form, similar to other stable iodine products such as KI tablets or liquid solutions. All deliver iodide ions for thyroid protection, but differences may exist in dosage strength, formulation excipients, and regulatory status. Selection depends on clinical guidelines, patient preference and supply considerations.

Jodid should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. No refrigeration is required for this oral potassium iodide product.

Jodid is taken orally, usually as a tablet or liquid as directed by a healthcare professional. It should be swallowed with water unless the prescriber advises an alternative method. The exact administration schedule is individualized based on the indication and patient factors.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, significant thyroid dysfunction (hypo‑ or hyperthyroidism), iodide toxicity, and pulmonary edema. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, rash, or swelling.

Jodid should be avoided in individuals with known hypersensitivity to potassium iodide or any excipients, those with certain thyroid disorders (e.g., untreated hyperthyroidism) without specialist supervision, and patients with severe renal impairment unless closely monitored. Consultation with a healthcare provider is essential before starting therapy.